Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptor 1 and Toll-like receptor 2 (TLR1 and TLR2) are cell-surface pattern recognition receptors that play a critical role in the innate immune system by detecting pathogen-associated molecular patterns (PAMPs) from bacteria, fungi, and other microbes[1][2][5][6][7]. Both are type I transmembrane proteins with extracellular leucine-rich repeat (LRR) domains for ligand recognition, a single transmembrane helix, and an intracellular Toll/interleukin-1 receptor (TIR) domain for signal transduction[5][6]. TLR1 and TLR2 commonly function as a heterodimer, recognizing bacterial lipoproteins and lipopeptides and initiating MyD88-dependent (and to a lesser extent, TRIF-dependent) intracellular signaling cascades[3][4][7]. Their activation results in the production of pro-inflammatory cytokines, linking the innate and adaptive immune response, but their dysregulation is implicated in infectious, inflammatory, and autoimmune diseases[6][7][1]. If you need further breakdown for each individual receptor (TLR1 or TLR2), specify which, as both frequently function together as a heterodimer for ligand recognition and downstream signaling[5][3].
Agonists: Trigger TLR1/2 dimerization and downstream MyD88-dependent signaling, promoting immune response Antagonists: Block ligand binding, preventing receptor activation and reducing inflammation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like receptor 1 and Toll-like receptor 2 (TLR1 and TLR2).